MarketFriction

Healthfore Technologies Ltd

BSE 533525 · Computers - Software & Consulting
Market cap₹5.40 Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017
Revenue from operations4333108352442
Operating costs555487653344
EBITDA-0-2-2-121-30-21-0-2
EBITDA margin %-8%-74%-85%-50%19%12%-125%9%-119%26%-3.1%-76%
Depreciation & amortisation211112221111
Finance costs1717171718202020211988
Non-operating income2211000006400
Pre-tax profit-17-18-20-19-17-20-25-21-2445-9-11
Effective tax rate %0%0%0%0%0%0%0%0%0%0%0%0%
Profit after tax-17-18-20-19-17-20-25-21-2445-9-11
Earnings per share (Rs)-20.36-22.49-24.02-23.31-20.71-24.22-30.31-25.67-29.2855.45-11.05-13.92
Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017TTM
Revenue from operations125.1793.5261.9221.2227.2519.8318.3617.3111.31
Operating costs156.11134.9185.2937.2435.5620.8622.0620.8813.68
EBITDA-30.94-41.39-23.37-16.02-8.31-1.03-3.70-3.57-2.37
EBITDA margin %-24.72%-44.26%-37.74%-75.49%-30.50%-5.19%-20.15%-20.62%-20.95%
Depreciation & amortisation4.2212.3016.9512.6512.647.795.615.985.89
Finance costs6.7917.5147.3049.1346.9361.3868.7980.7455.74
Non-operating income1.521.0314.699.912.3110.604.501.3264.97
Pre-tax profit-40.43-70.17-72.93-67.89-65.57-59.60-73.60-88.970.97
Effective tax rate %0.35%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Profit after tax-40.57-70.17-72.93-67.89-65.57-59.60-73.60-88.970.98
Earnings per share (Rs)-86.32-89.71-83.51-80.66-73.31-90.53-109.441.20
Paid out as dividend %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Revenue CAGR%-23%-14%-56%
Profit CAGR%-6%-14%24%
Share price CAGR-12%%%%
Average return on equity%%%%
Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Net block (property, plant)38.0447.0330.3916.3313.3532.3538.0932.49
Capital work in progress0.160.005.1914.5415.080.010.0011.50
Investments3.093.093.093.094.410.000.000.00
Current & other assets55.7875.41190.5046.3452.77114.3860.0857.52
Total assets97.07125.53229.1780.3085.61146.7498.17101.51
Share capital8.138.138.138.138.138.138.138.13
Reserves & surplus-51.26-121.43-194.36-262.25-327.82-387.60-461.21-550.18
Total debt35.01208.67392.18316.17393.23507.52529.52588.87
Other liabilities & provisions105.1930.1623.2218.2512.0718.6921.7354.69
Equity + liabilities97.07125.53229.1780.3085.61146.7498.17101.51
Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Operating cash flow54.64-73.16-30.10-15.259.37-48.9459.7764.91
Investing cash flow-29.51-21.85-112.80137.02-16.37-9.33-7.96-11.43
Free cash flow (after capex)28.22-94.41-38.16-23.27-1.25-61.0248.4053.01
Financing cash flow-25.40100.87139.52-123.518.9357.09-52.01-55.17
Net change in cash-0.275.86-3.38-1.741.93-1.18-0.20-1.69
Cash conversion (OCF / EBITDA) %-177%177%129%95%-113%4,751%-1,615%-1,818%
Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017
Return on capital employed %-120.44%-15.31%-13.94%-27.01%0.32%-4.68%-13.34%
Receivable days88.1888.2869.85116.62137.70230.45247.31235.74
Inventory days19.2832.0835.78276.5891.25
Payable days139.9566.9132.31215.37165.31
Cash cycle (days)-32.4953.4573.32177.8363.64230.45247.31235.74
Working capital days-147.35-115.14-810.76-5,272.20-2,552.72-3,256.65-5,997.65-9,554.52
Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018
Promoter group %49.44%49.44%49.44%49.44%49.44%49.44%49.44%49.44%49.44%
Foreign investors %3.04%3.04%3.04%3.04%2.09%2.05%2.05%1.90%1.86%
Retail & others %47.52%47.52%47.52%47.52%48.47%48.51%48.51%48.67%48.71%
Shareholder count12,86612,81912,75912,67212,53612,54312,48311,32111,321

Fundamentals

Market value₹ 5.40 Cr.
Last price₹ 6.64
Book value / share₹ -637
Return on capital-13.3 %
Return on equity%
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)-56%
Profit CAGR (TTM)24%
Standalone figures.
Valuation
P/B, 3-year average-0.06x
P/B, 5-year average-0.07x
Profitability
Operating margin (excl. other income)-5.19%
Operating margin (incl. other income)48.26%
EBITDA margin553.49%
Pre-tax margin8.58%
Net profit margin8.66%
Net margin, latest quarter-563.18%
ROE17.05%
ROCE1.77%
ROA-51.30%
ROE, 3-year average23.58%
ROCE, 3-year average-13.24%
ROA, 3-year average-58.07%
ROE, 5-year average41.83%
ROCE, 5-year average-35.49%
ROA, 5-year average-55.68%
ROIC (approx.)46.34%
Other income / net worth-2.79%
Growth
Sales growth (latest year)-27.23%
Sales CAGR, 3 years-31.58%
Sales CAGR, 5 years-30.82%
Sales growth QoQ-42.90%
Sales growth YoY (latest quarter)-62.00%
Per share
EPS (TTM)Rs 1.21
EPS (latest year)Rs -73.31
EPS (latest quarter)Rs -13.92
EPS, 3-year averageRs -79.16
EPS, 5-year averageRs -82.70
Book value per shareRs -466.78
Sales per shareRs 13.91
Cash flow per shareRs -60.20
Efficiency
Asset turnover0.14x
Fixed asset turnover0.61x
Debtor days230 days
Debtors turnover1.58x
Leverage
Total debtRs 508 Cr
Cash and bankRs 6 Cr
Net debtRs 502 Cr
Debt to equity-1.34x
Net debt / EBITDA8.02x
Interest coverage1.02x
Owners' fund to total sources-258.60%
Debt to assets345.86%
Cash flow
Operating cash flow (latest year)Rs -49 Cr
Investing cash flow (latest year)Rs -9 Cr
Financing cash flow (latest year)Rs 57 Cr
Net change in cash (latest year)Rs -1 Cr
Statement figures
Net sales (TTM)Rs 11 Cr
Net sales (latest year)Rs 20 Cr
Sales (latest quarter)Rs 2 Cr
Operating profit excl. other income (latest year)Rs -1 Cr
Operating profit (latest quarter)Rs -2 Cr
Other income (TTM)Rs 65 Cr
EBITDA (TTM)Rs 63 Cr
PBDT (TTM)Rs 7 Cr
Profit before tax (TTM)Rs 1 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs -60 Cr
Net profit (latest quarter)Rs -11 Cr
Depreciation (TTM)Rs 6 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 56 Cr
Cost of goods sold (latest year)Rs 2 Cr
Total expenditure (latest year)Rs 21 Cr
Total income (latest year)Rs 30 Cr
Share capitalRs 8 Cr
ReservesRs -388 Cr
Shareholders' fundsRs -379 Cr
Total assetsRs 147 Cr
Net blockRs 32 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 13 Cr
Other liabilitiesRs 19 Cr
Shares outstanding (crore)0.81
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 5 of 8
seriousNegative equity Shareholders' equity is negative
explainReceivables outrunning sales Receivables grew 22% vs sales -27% in 2017
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Dec 2017
Sales ₹2 Cr -60.0% vs Dec 2016. Net loss ₹11 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Tata Consultancy Services Ltd735,34013.763.0 %
Infosys Ltd412,07713.240.0 %
HCL Technologies Ltd331,61018.330.4 %
Wipro Ltd155,30411.817.8 %
Tech Mahindra Ltd148,05327.823.1 %
LTM Ltd116,75020.829.6 %
Persistent Systems Ltd81,43140.934.4 %
Coforge Ltd76,29139.823.5 %
Mphasis Ltd41,13821.222.1 %
Hexaware Technologies Ltd29,45720.830.1 %
Tata Elxsi Ltd20,01128.430.0 %
KPIT Technologies Ltd14,24722.826.3 %
IDream Film Infrastructure Company Ltd13,309%
Fractal Analytics Ltd13,07639.412.6 %
ASM Technologies Ltd10,02013727.0 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Healthfore Technologies Ltd?

Healthfore Technologies Ltd (533525) has a market capitalisation of Rs 5.40 Cr. at the close.

What were Healthfore Technologies Ltd's latest quarterly results?

In the Dec 2017 quarter, Healthfore Technologies Ltd sales was Rs 2 Cr (-60.0% vs Dec 2016) with a net loss of Rs 11 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03